ORIC

Conviction 77HealthcareScan · Mon, Aug 10, 2026

ORIC$13.61+0.81%

ResistanceSupportVol 14Insider sell

Vol MA14 2.15M

May 11May 28Jun 16Jul 6Jul 23Aug 10

Oric Pharmaceuticals, Inc.PHARMACEUTICAL PREPARATIONSwww.oricpharma.com ↗

Price13.61

Change+0.81%

Gap-0.74%

Rel volume2.05×

Avg volume1.9M

Avg $ vol22.68M

SMA 2011.66

SMA 5010.18

SMA 20010.57

Price vs 50+33.64%

Price vs 200+28.72%

MA stackmixed

50/200 cross—

Supertrendup · 10.63

RSI (14)67

MACD hist0.17

MACD crossbull · 4d

Stoch %K / %D88 / 81

ADX (14)41

+DI / −DI32 / 10

RSI divergence—

MACD divergenceBearish

ATR %+6.56%

ADR %7.62%

52w high14.41

52w low7.48

From 52w high-5.55%

Above 52w low+82.07%

New 52w highNo

SqueezeOff

Bollinger width36.46%

%B0.96

Donchian pos88.27%

Donchian high14.05

Donchian low10.30

AVWAP (52w high)10.62

vs AVWAP high+28.14%

AVWAP (52w low)9.86

vs AVWAP low+38.02%

OBV trendUp

Chaikin MF (20)0.12

Today vs 20d2.05×

Avg vol (14d)2.15M

Avg vol (20d)1.9M

Avg $ vol (20d)22.68M

Market cap—

RS 3m (vs SPY)+47.54%

RS 6m (vs SPY)+21.43%

RS line new highYes

Trend template5/8

Technical rank90.2

1 week+28.40%

1 month+25.44%

3 months+53.79%

6 months+30.61%

1 year+41.33%

YTD+66.59%

P/E-10.79

P/B3.66

P/S—

P/FCF-12.51

EPS-1.47

Div yield—

ROE-33.96%

ROA-31.99%

Debt/Eq0.03

Current13.19

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth-1.27%

Price target21.33

Target upside58.23%

Analyst ratingBuy

Institutional116.87%

Ent. value1.37B

Revenue—

Net income-41.49M

Gross profit—

Free cash flow-111.68M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out103.52M

Employees104

ListedFri, Apr 24, 2020

Free float—

Float %—

Short interest—

Days to cover—

Short volume—

Squeeze score—

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeA

Conviction77 / 100

Pattern quality—

Tech rank90.2 / 100

Group rank86 / 100 · Leading

Status laneNo active setup

Setup direction—

Pattern family

Resistance13.31

Support10.30

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in ORIC

All disclosures →

No recent disclosed trades by Congress in ORIC. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in ORIC · 1 buy · 4 sells

Insider	Side	Shares	Value	Traded	Filed
Heyman Richard A. Director · Common Stock · 2026-07-24	Exercise	3.5K	$6K	2026-07-24	2026-07-28
Heyman Richard A. Director · Common Stock · 2026-07-24	Sell	7K	$84K	2026-07-24	2026-07-28
Heyman Richard A. Director · Common Stock · 2026-07-24	Sell	6.1K	$73K	2026-07-24	2026-07-28
Heyman Richard A. Director · Stock Option (right to buy) · 2026-07-24	Exercise	3.5K	—	2026-07-24	2026-07-28
Heyman Richard A. Director · Common Stock · 2026-07-06	Sell	300	$4K	2026-07-06	2026-07-08

SEC filings

EDGAR filings in ORIC · 6 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.